Metabolism-Clinical and Experimental

Article	Citations
Characterization of Lipoprotein(a) Measurement in a Large US Healthcare Dataset	770
The Conicity Index in Identification of Cardiorenal Metabolic Syndrome Patients at Increased Risk for Complications	570
EMI Not Just BMI: Unveiling Hidden Diabetes Risk Among Apparently Healthy U.S. Young Adults	220
Lifestyle and Affective Emotions in Patients with Type 2 Diabetes Mellitus, With or Without COVID-19 History	210
Natural selection signatures of 65 syndromic and 8 monogenic obesity genes in 7 ethnic groups do not support the thrifty genotype hypothesis	179
MASLD may influence female-specific cancer risk indirectly through shared metabolic pathways rather than direct causation	179
Brown adipose tissue-derived metabolites and their role in regulating metabolism	166
Increased activity of the metalloproteinase PAPP-A promotes diabetes-induced glomerular hypertrophy	162
Healthcare Professionals’ Perceptions of Obesity & Agonists of the Glucagon, GLP-1 & GIP Receptors	157
A Phase II, randomized, double-blind, placebo-controlled, dose-finding study of survodutide (BI 456906) in people living with overweight/obesity	129
PCSK9 in metabolism and diseases	124
Editorial Board	123
Comparative efficacy of Gan & Lee insulin aspart (GL-ASP) and EU-marketed insulin aspart (NN-ASP), when combined with metformin, in patients with diabetes mellitus: Post-hoc analyses from a multic	122
Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4	117
Effects of intraduodenal infusion of lauric acid and L-tryptophan, alone and combined, on glucoregulatory hormones, gastric emptying and glycaemia in healthy men	115
Editorial Board	113
Prevalence of Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes and High Blood Pressure: Results from CATALYST	112
The risk and benefit of revisional vs. primary metabolic- bariatric surgery and drug therapy - A narrative review	107
PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy	107
The role of active vitamin D in preventing sarcopenia—Authors' reply	104
Serine active site containing protein 1 depletion alters lipid metabolism and protects against high fat diet-induced obesity in mice	90
Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states	88
Interplay of skeletal muscle and adipose tissue: sarcopenic obesity	81
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis	79
RETRACTED: Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in metabolic dysfunction-associated steatotic liver disease	77

Protein oxidation in non-exercising healthy adults under varying dietary conditions: Physiological determinants, effects on fuel partitioning, and implications for body weight regulation	75
Comprehensive assessment of the causal effects and metabolite mediators of glucose-lowering drug targets on cardio-renal-liver-metabolic health	73
Exercise training increases skeletal muscle sphingomyelinases and affects mitochondrial quality control in men with type 2 diabetes	73
Hepatocyte TIPE2 is a fasting-induced Raf-1 inactivator that drives hepatic gluconeogenesis to maintain glucose homeostasis	68
Editorial Board	67
Leveraging Automated Machine Learning to provide NAFLD screening diagnosis: Proposed machine learning models	67
Blood based biomarkers as non-invasive screening tools for hepatic fibrosis in subjects with Type 2 Diabetes Mellitus	66
Impact of fasting on the AMPK and PGC-1α axis in rodent and human skeletal muscle: A systematic review	63
Association between hypertension and severity of NAFLD among adults with obesity	61
Corrigendum to “FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis” [Metabolism 122 (September 2021) 154840]	61
Editorial Board	61
Fatty acid metabolism: The crossroads in intestinal homeostasis and tumor	61
Risk of Obesity, Diabetes, Insulin resistance, and Dyslipidemia among Irritable Bowel Syndrome patients	60
The relationship between Vitamin D level and Sarcopenia: Insights from a Korean Population Study	60
Relationship between Obesity Indices Measured with Body Composition Analyzer and Carotid Artery Plaques in Korean Middle-Aged Men	59
Higher Resource Utilization And Mortality Among Patients With Heart Failure Admited With Diabetic Ketoacidosis And Chronic Kidney Disease	58
Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease	58
Uncovering mechanisms of thiazolidinediones on osteogenesis and adipogenesis using spatial fluxomics	57
Pharmacologically targeting fatty acid synthase-mediated de novo lipogenesis alleviates osteolytic bone loss by directly inhibiting osteoclastogenesis through suppression of STAT3 palmitoylation and R	57
Role of mitochondria in pathogenesis and therapy of renal fibrosis	56
Exercise alleviates neovascular age-related macular degeneration by inhibiting AIM2 inflammasome in myeloid cells	56
Sterol carrier protein 2 in lipid metabolism and non-alcoholic fatty liver disease: Pathophysiology, molecular biology, and potential clinical implications	55
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity	55
Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis	54
Editorial Board	53
Neuroprotective effect of small extracellular vesicle-mediated targeting of AMPKα2 in cerebral ischemia	52
Role of Coronary Artery Calcium in the Association Between Hormone Replacement Therapy Status and Incident Death and Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis	52
Biological effect of nicotiflorin against acute myocardial Infarction: Therapeutic role in the medicine through scientific data analysis	51
Real-world outcomes in people with type 2 diabetes (PWD2) and renal impairment receiving insulin glargine 300 U/mL (Gla-300) and insulin degludec 100U/mL or 200U/mL (IDeg): the DELIVER-R study	50
Editorial Board	48
Response to letter by Muralidhar and Madhivanan: Clarity and quality assessment of epidemiology of sarcopenia: Prevalence, risk factors, and consequences	47
Relationship between circulating adipokines and cholesterol efflux in subjects with severe carotid atherosclerosis	47
Endothelial sodium channel activation mediates DOCA-salt-induced endothelial cell and arterial stiffening	47
Editorial Board	46
Editorial Board	46
Fueling the fight against cancer: Exploring the impact of branched-chain amino acid catalyzation on cancer and cancer immune microenvironment	45
Best practice recommendations for the diagnosis and management of hypoparathyroidism	45
Identifying proteins and pathways associated with multimorbidity in 53,026 adults	45
Pegozafermin Added to Background GLP-1 Therapy Led to Greater Improvement in Non-invasive Markers of Liver Fat, Injury and Fibrosis as well as Glycemic Control in NASH Patients with F2/F3 Fibrosis at	44
The LS-IM score and its relation to direct measurements of insulin resistance	44
Association of eating-out rate with metabolic syndrome in Korean adults: from the Korean National Health and Nutrition Examination Survey 2016	44
A multi-metabolite signature robustly predicts long-term mortality in the PREDIMED trial and several US cohorts	43
Nutritional Management of Patients with Obesity in Critical Care	43
Corrigendum to “Prolonged increase in glutamate whole body and intracellular production in older adults with COPD and healthy controls post-resistance exercise” [Metabolism, Volume 168, July 2025, 156	43
Clinical and Biochemical Characteristics of Children and Adolescents with Type 1 Diabetes in Mexico	43
Biological importance of prunin in the medicine for the treatment of diabetes related complication: Therapeutic benefit through data analysis	43
Insulin Resistance as Monitored by Dynamic Light Scattering of Whole Human Serum: An Ancillary Study of PREMIER	42
Deletion of BCATm increases insulin-stimulated glucose oxidation in the heart	42
Fyn deficiency inhibits oxidative stress by decreasing c-Cbl-mediated ubiquitination of Sirt1 to attenuate diabetic renal fibrosis	42
NIPSNAP1 and NIPSNAP2 facilitate healthy aging independent of mitophagy	42

NPRC promotes hepatic steatosis via USP30-mediated deubiquitination of C/EBPβ	41
Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies	41
Inverse Relationship Between Creatinine-to-Body Weight (Cre/BW) Ratio and Incident Diabetes in a Multiethnic Cohort	40
Editorial Board	40
Association Between Processed and Ultra-processed Food Intake and Cardiovascular Disease and its Risk Factors in Patients with Type 2 Diabetes	39
Preclinical insights into the potential of itaconate and its derivatives for liver disease therapy	39
New PET Measures of Functional Brain Fractal Dimensions Show Significant Differences for Cortical Grey and White Matter and also in Near Normal vs. Insulin Resistant Patients	37
Prevalence of Hypercortisolism in Patients with Difficult-to-control Type 2 Diabetes: Final Results from CATALYST Part 1	37
Analysis of Cardiovascular Complications during Delivery Admissions Associated with COVID-19	37
Disrupted metabolic flux balance between pyruvate dehydrogenase and pyruvate carboxylase in human fatty liver	36
Uric Acid and Treatment With Empagliflozin in Heart Failure with Preserved Ejection Fraction (HFpEF): the EMPEROR-Preserved Trial	36
Response to letter to the editor regarding: “Plasma metabolite profiles of meat intake and their association with cardiovascular disease risk: A population-based study in Swedish cohorts” by Arage et	35
Starvation and infection: The role of sickness-associated anorexia in metabolic adaptation during acute infection	35
Omentin-1 Levels and Endothelial Dysfunction in Diabetic Kidney Disease	35
Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts	35
Females have a different metabolic response to critical illness, measured by comprehensive amino acid flux analysis	35
Multiple Autoimmune Syndromes in Type 1 Diabetes	34
Anti-inflammatory activity of corylin in the medicine: Biological importance through scientific data analysis	34
Corrigendum to “The RNA binding protein HuR influences skeletal muscle metabolic flexibility in rodents and humans” [Metab. 97 (2019) 40–49]	34
Fat mass paradox and carotid intima-media thickness progression: A longitudinal study from childhood through young adulthood	34
T2DM Subgroups and Response to Glucose-lowering Therapy: Results from EDICT and Qatar Study	32
Serum metabolomics analysis reveals increased lipid catabolism in mildly hyperbilirubinemic Gilbert's syndrome individuals	32
SACUBITRIL/VALSARTAN TREATMENT MAY BE ASSOCIATED WITH IMPROVED FRONTAL PLANE QRS-T ANGLE AND CARDIAC REPOLARIZATION PARAMETERS.	32
The Association Between Adiponectin and Myocardial Infarction in Patients with Nonalcoholic Fatty Liver Disease	32
Recent advances and therapeutic applications of PPARγ-targeted ligands based on the inhibition mechanism of Ser273 phosphorylation	31
Pancreatic PCSK9 controls the organization of the β-cell secretory pathway via LDLR-cholesterol axis	30
Interplay of lipid metabolism and inflammation in podocyte injury	30
Commentary on the endocrine society clinical practice guideline on the “treatment of hypercalcemia of malignancy in adults”	30
Krüppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4α-mediated metabolic pathways	30
High levels of intracellular endotrophin in adipocytes mediate COPII vesicle supplies to autophagosome to impair autophagic flux and contribute to systemic insulin resistance in obesity	30
O-GlcNAcylation promotes the progression of nonalcoholic fatty liver disease by upregulating the expression and function of CD36	30
Evaluation of renal glucose uptake with [18F]FDG-PET: Methodological advancements and metabolic outcomes	29
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases	29
Prandial hepatic glucose production during hypoglycemia is altered after gastric bypass surgery and sleeve gastrectomy	29
Olfactomedin 2 deficiency protects against diet-induced obesity	28
Mevalonate pathway orchestrates insulin signaling via RAB14 geranylgeranylation-mediated phosphorylation of AKT to regulate hepatic glucose metabolism	28
The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation	28
Weight Loss: A Changing Paradigm in Insulin Resistant and Diabetic Patients	27
The mitochondrial NAD+ transporter SLC25A51 is a fasting-induced gene affecting SIRT3 functions	27
Patients With Diabetic Ketoacidosis Affected By Protein Calorie Malnutrition Have In-Patient High Mortality And Increased Resource Utilization, Nation Wide Study	27
Towards personalized genome-scale modeling of inborn errors of metabolism for systems medicine applications	27
The Role of Insulin Resistance in the Severity of PCOS Among a Population in Albania	27
C3aR1 on beta cells preserves beta cell function and glucose homeostasis in diabetic mice by decreasing metabolic stress and dedifferentiation	27
New onset Diabetes Mellitus in a COVID-19 patient: A Case report	26
The chemokine CCL20 promotes hepatocyte cholesterol deposition during metabolic dysfunction-associated steatohepatitis by regulating OLR1 expression	26
Effects of Semaglutide on Metabolic Syndrome Parameters in Non-Diabetics: A Meta-analysis of Randomized Controlled Trials	26
Editorial Board	26
Evaluation of the effect of β-Caryophyllene on oxidative stress in BALB / c mice with streptozotocin-induced diabetes	26
Blood C-Peptide Values are Impacted by the Collection, Storage and Evaluation Methods	26
Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response	26
Biological effect of ginkgetin on kidney injury: Health benefit in the medicine through scientific data analysis	26
Loss of metabolic adaptation in lean MAFLD is driven by endotoxemia leading to epigenetic reprogramming	26
Revisiting gender differences in obesity and type 2 diabetes: Letter to the editor	26
MASLD may influence female-specific cancer risk indirectly through shared metabolic pathways rather than direct causation - author's reply	25
NRH, a potent NAD+ enhancer, improves glucose homeostasis and lipid metabolism in diet-induced obese mice through an active adenosine kinase pathway	25
Sodium-dependent Glucose Transporter 2 Inhibitor Alleviates Renal Lipid Deposition and Improves Renal Oxygenation Levels in Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Randomized Controlled T	25
A healthy lifestyle, Life's Essential 8 scores and new-onset severe NAFLD: A prospective analysis in UK Biobank	25
VCAM-1-binding peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis	25
Renoprotective effects of genetically proxied fibroblast growth factor 21: Mendelian randomization, proteome-wide and metabolome-wide association study	25
Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled	25
Dyslipidemia Correction by Combination of Statin and Choline Fenofibrate in Diabetic Patients with Multifocal Atherosclerosis	25
Copper impairs the intestinal barrier integrity in Wilson disease	25
Association of PNPLA3 and TM6SF2 Polymorphisms with NAFLD in Greek People with Type 2 Diabetes Mellitus	24
Myocardial Ischemia in Type 2 Diabetic Patients	24
Arrestin domain containing 3 promotes alcohol-induced liver steatosis by reducing stearoyl-CoA desaturase-1 ubiquitinated degradation	24
Prevalence and Clinical Characteristics of Patients with Transthyretin Amyloidosis in the United States and Japan: Results from the OverTTuRe Study	24
Metformin and the heart: Update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure	24
Corrigendum to “Increased adrenal steroidogenesis and suppressed corticosteroid responsiveness in critical COVID-19” [Metabolism volume 160 (2024) 155980]	24
Protein kinase N1 deficiency results in upregulation of cerebral energy metabolism and is highly protective in in vivo and in vitro stroke models	24
Propionyl-L-Carnitine in Patients with Type 2 Diabetes and Peripheral Artery Disease	24
Sodium-glucose cotransporter-2 inhibitors: A treatment option for recurrent vasovagal syndrome?	23
EFFECT OF ADMINISTRATION OF AVOCADO JUICE (PERSEA AMERICANA MILL) ON RAT-INDUCED MALONDIALDEHID (RATTUS NORVEGICUS) LEVELS	23
Role of SORT1 gene in patients with Coronary Artery Disease.	23
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease	22
Correlation of Insulin Resistance, Type 2 Diabetes Mellitus, Obesity, and Colorectal Cancer Occurrence	22
Acknowledgement to reviewers	22
Postpartum defects in inflammatory response after gestational diabetes precede progression to type 2 diabetes: a nested case-control study within the SWIFT study	22
Editorial Board	22
Shared genetic architecture of type 2 diabetes with muscle mass and function and frailty reveals comorbidity etiology and pleiotropic druggable targets	22
Trends in Hyperinsulinemia Among U.S. Adults without Diabetes: A Joinpoint Analysis	22

GDF-15 improves the predictive capacity of steatotic liver disease non-invasive tests for incident morbidity and mortality risk for cardio-renal-metabolic diseases and malignancies	21
Metabolites-mediated posttranslational modifications in cardiac metabolic remodeling: Implications for disease pathology and therapeutic potential	21
Connecting nutritional deprivation and pubertal inhibition via GRK2-mediated repression of kisspeptin actions in GnRH neurons	21
Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study	21
Effects of ileal glucose infusion on enteropancreatic hormone secretion in humans: relationship to glucose absorption	21
The zebrafish model system for dyslipidemia and atherosclerosis research: Focus on environmental/exposome factors and genetic mechanisms	21
Identifying genetic determinants of sarcopenia-related traits: a Mendelian randomization study of druggable genes	21
Small extracellular vesicle targeting of hypothalamic AMPKα1 promotes weight loss in leptin receptor deficient mice	21
The role of histone deacetylases in cardiac energy metabolism in heart diseases	21
Kidney disease in diabetes: From mechanisms to clinical presentation and treatment strategies	21
Deciphering the molecular pathways of saroglitazar: A dual PPAR α/γ agonist for managing metabolic NAFLD	21
Association of serum vitamin D level and type 2 diabetes with nonalcoholic fatty liver disease	20
Insulin resistance and miR-143/miR-145 relative expression profile is associated with dysregulation in the pathological adiposity setting in aging	20
Effects Of Late Onset Estradiol Treatment On Insulin Resistance And Lipid Metabolism In High-Fat-Fed Ovariectomized Female Mice	20
Efficacy and Safety of Tirzepatide in Type 2 Diabetes: The SURPASS Clinical Trial Program	20
Reply to: “Precision nutrition in aging: Enhancing frailty prevention through personalized dietary interventions”	20
Cytochrome P450 oxidase 2J inhibition suppresses choroidal neovascularization in mice	20
Thymoquinone: A Promising Anti-diabetic Molecule!	20
Prevalence of Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes and Cardiovascular Disease: Results from CATALYST	20
Modulation of TREM-1, Arginase and Nitric Oxide Levels under Diabetic Conditions in Macrophages	20
Disruptive factors of treatment adherence of diabetic patients in downtown Sfax from Tunisia – a community pharmacy-based survey	19
Telomere length of the gums of patients with diabetes mellitus in non-alcoholic fatty liver disease	19
New insights into the function of the NLRP3 inflammasome in sarcopenia: mechanism and therapeutic strategies	19
Therapeutic importance of eriodictyol in the medicine for the treatment of diabetes and associated complication through its insulin secretagogue properties	19
Comparison of New-Onset Diabetes Mellitus among Patients with Atrial Fibrillation or Atrial Flutter	19
Corrigendum to ‘Targeting mammalian serine/threonine-protein kinase 4 through yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nep	19
Serum metabolomic profiling reveals potential biomarkers in systemic sclerosis	19
Editorial Board	19
The influence of metformin on the rate of Covid-19 vaccination among diabetes type 2 patients in Poland	19
Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation: A longitudinal and a case-control stu	19
Chemical discovery of a novel MD2/ADAM17 dual-target inhibitor as a potential therapeutic candidate for saturated fatty acid-induced myocardial inflammatory injury	19
Hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice	19
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus	18
Recent advances in closed-loop insulin delivery	18
EVALUATION OF 1-HOUR POST LOAD GLUCOSE LEVELS, THE METABOLIC SYNDROME AND FINDRISC SCORES IN THE PREDICTION OF T2DM IN PATIENTS WITH IMPAIRED FASTING GLUCOSE	18
Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond	18
Mitochondria-SR interaction and mitochondrial fusion/fission in the regulation of skeletal muscle metabolism	18
Value of breastfeeding in Pregnant with gestational diabetes mellitus	18
A polyphenol-rich green Mediterranean diet enhances epigenetic regulatory potential: the DIRECT PLUS randomized controlled trial	18
Lysine potentiates insulin secretion via AASS-dependent catabolism and regulation of GABA content and signaling	18
Prognostic Fasting Insulin Cut Points for Hidden Diabetes Risk among Apparently Healthy Young Adults: CARDIA 30-year Follow Up	18
Intermittent fasting and neurodegenerative diseases: Molecular mechanisms and therapeutic potential	18
LAT1-dependent placental methionine uptake is a key player in fetal programming of metabolic disease	18
Central NUCB2/nesfatin-1 signaling ameliorates liver steatosis through suppression of endoplasmic reticulum stress in the hypothalamus	18
FSH exacerbates bone loss by promoting osteoclast energy metabolism through the CREB-MDH2-NAD+ axis	18
SGLT2-inhibitors reduce the cardiac autonomic neuropathy dysfunction and vaso-vagal syncope recurrence in patients with type 2 diabetes mellitus: the SCAN study	18
A Rare Cause of Severe Insulin Resistance: A Case Report	18
Associations of single nucleotide variants of the FTO gene with metabolic disorders in children with obesity	18
Primary cilia regulate adaptive responses to fasting	18
Joint effect of blood pressure and glycemic variation on the risk of cardiovascular morbidity and mortality in persons with type 2 diabetes	18
Effects of statins on specialized pro-resolving mediators: An additional pathway leading to resolution of inflammation	18
Leptin acutely increases hepatic triglyceride secretion in patients with lipodystrophy	17
Influence of metabolic syndrome components in the course of covid-19 in patients with nonalcoholic fatty liver disease	17
ApoA-I mimetics favorably impact cyclooxygenase 2 and bioactive lipids that may contribute to cardiometabolic syndrome in chronic treated HIV	17
TAS2R38 taste receptor gene and metabolically unhealthy obesity	17
Unraveling the roles of mitochondrial sirtuins in aging-related diseases: From mechanistic insights to therapeutic strategies	17
Anti-atherosclerosis activity of meranzin hydrate in the medicine: Therapeutic benefit through scientific data analysis	17
Omega-3 Fatty Acids intervention and DASH Diet Ameliorates Metabolic profiling in Patients with Diabetes Mellitus Type 2	17
Metabolic complications of highly active antiretroviral therapy in adult HIV-infected patients with heart failure: A 7-year prospective cohort study	17
Alteration of IGF-1 bioavailability due to PAPPA2 deficiency leads to sex-specific metabolic disturbances	17
The Association Between Gestational Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Systematic Literature Review	17
Intravital imaging reveals glucose-dependent cilia movement in pancreatic islets in vivo	17
Transplantation of bone marrow cells from miR150 knockout mice improves senescence-associated humoral immune dysfunction and arterial stiffness	17
DR region of NKAα1 is a target to ameliorate hepatic lipid metabolism disturbance in obese mice	16
Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States	16
Zinc finger protein ZNF638 regulates triglyceride metabolism via ANGPTL8 in an estrogen dependent manner	16
Circulating Total and Intact GDF-15 Levels are Not Altered in Response to Weight Loss Induced by Liraglutide and/or Lorcaserin Treatment in Humans with Obesity and/or Diabetes	16
From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): an ongoing journey towards refining the terminology for this prevalent metabolic condition and unmet clinical need	16
FAM3A maintains metabolic homeostasis by interacting with F1-ATP synthase to regulate the activity and assembly of ATP synthase	16
Impaired unsaturated fatty acid elongation alters mitochondrial function and accelerates metabolic dysfunction-associated steatohepatitis progression	16
Insulin Resistance Probability Score and Cardiovascular Events in the Elderly	16
GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-β1/SMAD3 pathway	16
The bone-heart axis: A crucial dialogue in cardiovascular disease	16
Time-restricted eating and its impact on weight loss, adipose tissue distribution, lean mass and blood pressure in women with cardiometabolic risk factors	16
Flot2 protects against podocyte injury by maintaining the stability of synaptopodin in diabetic nephropathy	15
Global, regional, and national trends in metabolic risk factor-associated mortality among the working-age population from 1990-2019: An age-period-cohort analysis of the Global Burden of Disease 2019	15
Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical coronavirus disease 2019 outcomes than metabolically healthy individuals without obesity	15
REEP6 knockout leads to defective β-adrenergic signaling in adipocytes and promotes obesity-related metabolic dysfunction.	15
Editorial Board	15
Metabolic obesity phenotypes: a friend or foe of digestive polyps?—An observational study based on National Inpatient Database	15
The association of circulating fibroblast growth factor 21 levels with incident heart failure: The Multi-Ethnic Study of Atherosclerosis	15
Circulating total and intact GDF-15 levels are not altered in response to weight loss induced by liraglutide or lorcaserin treatment in humans with obesity	15
Prolonged increase in glutamate whole body and intracellular production in older adults with COPD and healthy controls post-resistance exercise	15
Expanding the clinical and immunogenomic relevance of SAMD1 in hepatocellular carcinoma	15
Liraglutide in Treatment of Diabetes Mellitus Type 2: Systematic Review and Bibliometric Analysis Over The Last Two Decades	15
Leptin receptor neurons in the dorsomedial hypothalamus require distinct neuronal subsets for thermogenesis and weight loss	15
Higd1a facilitates exercise-mediated alleviation of fatty liver in diet-induced obese mice	14
Impact of Insulin Resistance and Chronic Low-Grade Systemic Inflammation on Vascular Rigidity in Patients with Arterial Hypertension and Non-Alcoholic Fatty Liver Disease	14
Aldosterone Dysregulation and Type 2 Diabetes Mellitus Are Associated with Prevalent Risk of Hypertension: BREAKTHROUGH Risk Study	14
A partial loss-of-function variant (Ile191Val) of the TAS1R2 glucose receptor is associated with enhanced responses to exercise training in older adults with obesity: A translational study	14
Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation	14
IFT80 and TRPA1 cooperatively regulate bone formation by calcium signaling in response to mechanical stimuli	14
Biological potential and antioxidant activity of strictinin in the medicine through literature data analysis	13
High plasma and lingual uroguanylin as potential contributors to changes in food preference after sleeve gastrectomy	13
Correlation between lifestyles assessed with the FANTASTIC questionnaire and cardiovascular risk in workers of a Peruvian hospital	13